Company / Depreciation & Amortization
Imunon, Inc. Depreciation & Amortization History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$197.0K
FY2023
5-year range
$197.0K / $741.5K
FY2019-FY2023
Trend
-72.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 7 years, ranging from $197,000 in FY2023 to $741,524 in FY2021.
Based on SEC 10-K filings.
$197,000 in FY2023 with a 5-year CAGR of -18.7%.
Improved from $741,524 to $197,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -35.1%
- 5-Year CAGR
- -18.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.7%, indicating a declining trend.
- In FY2023, depreciation & amortization decreased 72.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $197.0K | -72.0% |
| FY2022 | $702.9K | -5.2% |
| FY2021 | $741.5K | +2.8% |
| FY2020 | $721.7K | +102.2% |
| FY2019 | $356.9K | -35.5% |
| FY2018 | $553.0K | +63.0% |
| FY2015 | $339.2K | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026